Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects

Centre Oscar Lambret490 enrolled

Overview

This study is a description of the radiation effects on the healthy tissues in patients receiving Anastrozole, sequential or in association with radiotherapy.

Study Type

OBSERVATIONAL

Enrollment

490

Conditions

Breast Cancer

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * Post-menopausal woman without superior age limit * No metastatic breast cancer, stade I-II, estrogen receptor positive or progesterone receptor positive, treated by conservative surgery or total mastectomy and requiring additive treatment by radiotherapy and hormonotherapy * The patients including in another clinical trial can be include in this observatory

Locations (29)

Centre Henri Becquerel

Amiens, France

Outcomes

Primary Outcomes

radiation side effects

Describe, in real situation, the ionisant radiation effects on the healthy tissues in patients receiving anastrazole in association or sequential with radiotherapy

Time frame: 5 years after the end of radiotherapy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.